BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 29204839)

  • 1. Prognostic value of a microRNA signature as a novel biomarker in patients with lower-grade gliomas.
    Qian Z; Li Y; Fan X; Zhang C; Wang Y; Jiang T; Liu X
    J Neurooncol; 2018 Mar; 137(1):127-137. PubMed ID: 29204839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and validation of a 21-mRNA prognostic signature in diffuse lower-grade gliomas.
    Song LR; Weng JC; Huo XL; Wang L; Li H; Li D; Wu Z; Zhang JT
    J Neurooncol; 2020 Jan; 146(1):207-217. PubMed ID: 31853837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying a new microRNA signature as a prognostic biomarker in colon cancer.
    Lv Y; Duanmu J; Fu X; Li T; Jiang Q
    PLoS One; 2020; 15(2):e0228575. PubMed ID: 32049961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A five-microRNA signature for individualized prognosis evaluation and radiotherapy guidance in patients with diffuse lower-grade glioma.
    Zhang JH; Hou R; Pan Y; Gao Y; Yang Y; Tian W; Zhu YB
    J Cell Mol Med; 2020 Jul; 24(13):7504-7514. PubMed ID: 32412186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA processing genes characterize RNA splicing and further stratify lower-grade glioma.
    Chai RC; Li YM; Zhang KN; Chang YZ; Liu YQ; Zhao Z; Wang ZL; Chang YH; Li GZ; Wang KY; Wu F; Wang YZ
    JCI Insight; 2019 Aug; 5(17):. PubMed ID: 31408440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Risk Score Signature Consisting of Six Immune Genes Predicts Overall Survival in Patients with Lower-Grade Gliomas.
    Wu Y; Peng Z; Gu S; Wang H; Xiang W
    Comput Math Methods Med; 2022; 2022():2558548. PubMed ID: 35186111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a microRNA signature associated with survivability in cervical squamous cell carcinoma.
    Ma C; Zhang W; Wu Q; Liu Y; Wang C; Lao G; Yang L; Liu P
    PLoS One; 2018; 13(3):e0193625. PubMed ID: 29513728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of a seven-microRNA classifier as a novel biomarker for the prediction and detection of recurrence in glioma patients.
    Chen W; Yu Q; Chen B; Lu X; Li Q
    Oncotarget; 2016 Aug; 7(33):53392-53413. PubMed ID: 27438144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma.
    Zhao J; Wang L; Wei B
    Biomed Res Int; 2020; 2020():3708231. PubMed ID: 32802843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiogenomics of lower-grade gliomas: a radiomic signature as a biological surrogate for survival prediction.
    Qian Z; Li Y; Sun Z; Fan X; Xu K; Wang K; Li S; Zhang Z; Jiang T; Liu X; Wang Y
    Aging (Albany NY); 2018 Oct; 10(10):2884-2899. PubMed ID: 30362964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
    Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
    Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A four-protein expression prognostic signature predicts clinical outcome of lower-grade glioma.
    Patil V; Mahalingam K
    Gene; 2018 Dec; 679():57-64. PubMed ID: 30077762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a three-miRNA signature as a novel potential prognostic biomarker in patients with clear cell renal cell carcinoma.
    Luo Y; Chen L; Wang G; Xiao Y; Ju L; Wang X
    J Cell Biochem; 2019 Aug; 120(8):13751-13764. PubMed ID: 30957284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of a nine-gene signature in glioma patients based on mRNA expression profiling.
    Bao ZS; Li MY; Wang JY; Zhang CB; Wang HJ; Yan W; Liu YW; Zhang W; Chen L; Jiang T
    CNS Neurosci Ther; 2014 Feb; 20(2):112-8. PubMed ID: 24279471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of a novel microRNA-based signature for predicting the prognosis of glioma.
    Liu G; Rong X; Lin X; Wang H; He L; Peng Y
    Int J Neurosci; 2023 Dec; 133(8):840-850. PubMed ID: 35353669
    [No Abstract]   [Full Text] [Related]  

  • 17. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
    Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L
    Front Immunol; 2020; 11():603341. PubMed ID: 33363544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
    Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
    J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma.
    Huang QR; Li JW; Pan XB
    Medicine (Baltimore); 2021 Dec; 100(48):e28065. PubMed ID: 35049227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and prognostic value of microRNAs in lower-grade glioma depends on IDH1/2 status.
    Cheng W; Ren X; Zhang C; Han S; Wu A
    J Neurooncol; 2017 Apr; 132(2):207-218. PubMed ID: 28091987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.